Enzyme shot may displace cataract

September 2001
Ophthalmology Times;9/15/2001, Vol. 26 Issue 18, p15
Trade Publication
States that injections of an enzyme into each eye and an inexpensive pair of spectacles could restore vision to people in developing countries who are blind due to cataracts. Principle behind the procedure; Outcome of the procedure's trial that was conducted on animals; Remarks from Louis Girard, lead researcher of the trial.


Related Articles

  • An ancient record of 'couching' for cataract. Swan, H. T. // Journal of the Royal Society of Medicine;Apr1995, Vol. 88 Issue 4, p208 

    The article presents very early clinical case history which illustrates successful treatment of blindness secondary to cataract. The Book of Tobit in the Old Testament of the Bible provides such a case report. The technique used on Tobit may be called unorthodox couching. Couching for cataract...

  • Helping Your Body Heal Itself. Toohey, Lynn // American Chiropractor;2002, Vol. 24 Issue 2, p29 

    Relates the author's experience on the effectiveness of enzyme supplementation in the healing process occurring after inflammation. Effects of vitamin C; Importance of calcium, magnesium and manganese; Health benefits of anti-inflammatory nutrients.

  • Enzyme replacement therapy. Roth, Karl S. // Clinical Pediatrics;Mar1997, Vol. 36 Issue 3, p147 

    Editorial. Focuses on the barriers to accomplish enzyme replacement therapy. Problem of where to find the normal enzyme with which to fight the therapeutic battle; Protein stability; Immunogenicity if the source is other than human; Appropriate intracellular localization to optimize function...

  • Enzyme-potentiated desensitization (EPD) is back. Pulec, Jack L. // ENT: Ear, Nose & Throat Journal;Mar2002, Vol. 81 Issue 3, p131 

    Editorial. Announces the availability of enzyme-potentiated desensitization (EDP) treatment for allergies in the U.S. Requirements for the use of EDP; Significance of EDP in medical care administration.

  • Clinical trial shows safety and efficacy of agalsidase beta.  // Ophthalmology Times;10/15/2003, Vol. 28 Issue 20, p27 

    Focuses on the clinical trial for the safety and efficacy of agalsidase beta, an enzyme replacement therapy for the treatment of Fabry's disease. Prevention of reactions associated with the enzyme infusion; Assessment of the levels of globotriaosylceramide inclusions in the renal interstitial...

  • 'Relatively' painless wound debridement. Welch, Lynne Brodie // RN;Oct83, Vol. 46 Issue 10, p39 

    Presents an overview of the indications, contraindications and approved methodology for enzymatic debridement. Advantages of enzymatic debridement; Process of removing necrotic tissue through enzymatic action; Factors to consider in assessing the wound during enzymatic debridement. INSETS:...

  • Short-Term Treatment of Painful Osteoarthritis of the Knee with Oral Enzymes: A Randomised, Double-Blind Study versus Diclofenac. Klein, G.; Kullich, W. // Clinical Drug Investigation;2000, Vol. 19 Issue 1, p15 

    Objective: To compare the short-term efficacy and tolerability of an oral enzyme therapy with the NSAID diclofenac in patients with symptomatic osteoarthritis of the knee (gonarthritis). Methods: In a double-blind clinical trial, 73 patients with painful gonarthritis were randomised to receive 3...

  • Is telomerase a universal cancer target? Morin, Gregg B. // JNCI: Journal of the National Cancer Institute;6/21/95, Vol. 87 Issue 12, p859 

    Editorial. Discusses the possibility that the enzyme telomerase is the cellular component absolutely required for growth of all cancers but not for normal cells. Examination of issues associated with using telomerase and telomeres in cancer therapy; Cellular immortality; Potential side effects...

  • Neuroscience: Enzyme helps pain persist.  // Nature;12/9/2010, Vol. 468 Issue 7325, p735 

    The article highlights a study conducted by Bong-Kiun Kaang at Seoul National University in South Korea, Min Zhuo at the University of Toronto in Ontario and their colleagues which reveals the capacity of an enzyme with a peptide inhibitor to alleviate body pain.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics